TRAINING PROGRAM TOPICS

“Dr. Chasnoff’s series on The Mystery of Risk was fascinating! I learned so much. Dr. Chasnoff presented the information logically and sequentially to help those of us in the social and human services field understand complicated brain and medical conditions that lead to complicated health outcomes in young children. I also appreciated the presentation of behavior management strategies for children affected by alcohol and drugs. I highly recommend Dr. Chasnoff’s Mystery of Risk presentation.”
— Megan Johnson, Program Coordinator, Shasta First 5

Select from the following menu of topics to design the training program that will meet your target audience’s needs. Choose any combination of the following topics based on your budget and training needs.

Contact us with questions or to schedule your online training

I. EPIDEMIOLOGY OF SUBSTANCE USE IN PREGNANCY

  1. National surveys

  2. State studies

  3. Community evaluation

II. IDENTIFICATION OF THE PREGNANT WOMAN AT RISK FOR SUBSTANCE USE/MISUSE

  1. Use of a screening instrument in the primary health care setting

  2. Toxicology issues

    • Urine

    • Meconium

    • Hair

  3. Developing a comprehensive SBIRT system for pregnant women

III. PSYCHOSOCIAL ISSUES AND TREATMENT IMPLICATION FOR PREGNANT WOMEN USING DRUGS AND ALCOHOL

  1. Gender-Specific Issues for Women

    • Dual diagnosis

    • Violence

    • Sexual abuse

  2. Cognitive Functioning

    • Intellectual capabilities

    • Achievement

  3. Parenting Issues

    • Family history

    • Cultural influence

    • Developing expectations

  4. Trauma-influenced behaviors

    • Understanding trauma histories

    •Incorporating trauma-informed practices into maternal care

  5. Medication assisted treatment for pregnant women

  6. Therapeutic maternal/child interventions

    • Gender-specific treatment for women

    • Infant mental health

    • Dyadic therapy

  7. The neurobiology of attachment in the maternal/child dyad affected by prenatal substance use and misuse

IV. MATERNAL CONSEQUENCES OF PARENTAL DRUG OR ALCOHOL USE

  1. Pregnancy outcome

  2. Intervention strategies

    • Brief interventions

    • Motivational interviewing

V. FETAL ALCOHOL SPECTRUM DISORDERS

  1. Growth

  2. Facial dysmorphology

  3. CNS effects

    • Cognitive functioning

    • Behavior

    • Information processing

VI. PRENATAL ALCOHOL AND DRUG EXPOSURE: THE GROWING CHILD

  1. Long-term impact on child

    • Growth

    • Health

    • Neurodevelopment: Neuro-cognitive, self-regulation, adaptive functioning

  2. Implications for intervention

    • Psychological

    • Legal

    • Family-based strategies

    • The role of the child welfare system

  3. CAPTA

  4. The online world: Elements of risk for the child/teen with FASD

VII. NEONATAL OUTCOME

  1. Growth patterns

  2. Morbidity and mortality

  3. Infectious disease

    • Syphilis

    • HIV

    • Hepatitis B and C

  4. Neonatal Abstinence Syndrome (NAS)

    • Changing pattern of opiate misuse

    • Neonatal symptomatology

    • Differentiating NAS from neuro-behavioral deficits in the newborn

    • Assessment: Eat/sleep/console

    • Treatment of the neonate

  5. Marijuana use in pregnancy

    • Neonatal and child outcome

    • Public health perspective

  6. Neurobehavior

    • Newborn behaviors: Motor, orientation, state regulation

    • Intervention strategies: sensory integration, parenting interventions

    • Neurobehavior versus NAS

  7. Implications for early attachment

VIII. BEHAVIORAL MANAGEMENT AND INTERVENTIONS FOR THE CHILD PRENATALLY EXPOSED TO ALCOHOL OR DRUGS

  1. Infants and preschool

  2. School-aged children and adolescents

    • Regulatory disorders

    • Developing social skills

    • Understanding learning problems

    • Educational interventions

  3. Family- and agency-based interventions

  4. School-based interventions

IX. EDUCATIONAL INTERVENTION FOR THE CHILD AFFECTED BY PRENATAL SUBSTANCE EXPOSURE

  1. Effective educational strategies

  2. Social-emotional learning

  3. Building the home/school bridge

X. ADDRESSING THE NEEDS OF THE COMPLEX CHILD WITH PRENATAL AND POST-NATAL TRAUMA

  1. Polyvagal theory in trauma therapy

  2. Window of tolerance

  3. Practical clinical application of trauma theory

  4. Using a genogram to map out intergenerational transmission and influence of trauma

  5. Assessing quality of relationships

  6. Using Theraplay® to build family relationships

XI. CLINICAL ISSUES FOR ASSESSING AND TREATING CHILDREN AND FAMILIES

  1. Standardized testing: what it means

  2. Diagnostic interview, integrating test results, and developing a case summary and recommendations

  3. Reflective peer consultation

  4. Secondary trauma

  5. Special considerations when working with adoptive families

  6. Stories from families who have adopted a child with FASD

  7. Relational psychotherapy in a world of evidence-based approaches

  8. How to complete a trauma assessment in a community setting

  9. Integrating an outpatient therapy model into a school setting

XII. THE ROLE OF THE COURTS

  1. Child welfare

  2. FASD as a mitigating factor

  3. Adjudication

  4. Sentencing

XIII. IS PREVENTION AN ETHICAL OBLIGATION?

  1. The scientific foundation of ethical decision-making

  2. Key principles of ethical decision-making

  3. The intersection of medicine, law, and politics

The following topics are covered in the Leadership Institute

XIV. ORGANIZATIONAL DEVELOPMENT AND MANAGEMENT

  1. Vision, mission, and action planning

  2. The quality of leadership

    • Day-to-day management and decision making

    • Leadership through crisis

  3. Handling the shadow side fo organizational management

  4. Developing a strategic plan for social media

  5. Addressing secondary trauma in staff

XV. STRATEGIC PLANNING: DEVELOPING A SYSTEM OF CARE FOR CHILDREN AND FAMILIES

  1. Defining a system

  2. Creating partnerships

  3. Systems versus service integration

  4. Creating a 3-year strategic plan

    • Vision

    • Mission

    • Action plan

    • Sustainability: financial and human resources

  5. Evaluation